Rhumbline Advisers Meridian Bioscience Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $60,088 - $64,409	1,929 Added 2.03%	96,989 $3.22 Million
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $597,822 - $649,091	-19,347 Reduced 16.91%	95,060 $3 Million
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $148,295 - $197,872	-6,244 Reduced 5.18%	114,407 $3.48 Million
Q1 2022 May 12, 2022	SELL	$19.97 - $26.94 $114,607 - $154,608	-5,739 Reduced 4.54%	120,651 $3.13 Million
Q4 2021 Feb 10, 2022	BUY	$17.46 - $21.61 $31,043 - $38,422	1,778 Added 1.43%	126,390 $2.58 Million
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $272,395 - $353,250	-15,700 Reduced 11.19%	124,612 $2.4 Million
Q2 2021 Aug 05, 2021	BUY	$18.01 - $28.32 $147,177 - $231,431	8,172 Added 6.18%	140,312 $3.11 Million
Q1 2021 May 06, 2021	BUY	$19.76 - $29.89 $22,348 - $33,805	1,131 Added 0.86%	132,140 $3.47 Million
Q4 2020 Feb 10, 2021	BUY	$15.73 - $21.66 $82,944 - $114,213	5,273 Added 4.19%	131,009 $2.45 Million
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $118,908 - $231,932	-8,782 Reduced 6.53%	125,736 $2.14 Million
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $131,100 - $389,455	-16,722 Reduced 11.06%	134,518 $3.13 Million
Q1 2020 May 06, 2020	BUY	$5.57 - $11.5 $27,304 - $56,373	4,902 Added 3.35%	151,240 $1.27 Million
Q4 2019 Feb 05, 2020	BUY	$7.9 - $10.14 $49,698 - $63,790	6,291 Added 4.49%	146,338 $1.43 Million
Q3 2019 Oct 23, 2019	BUY	$9.17 - $12.01 $67,683 - $88,645	7,381 Added 5.56%	140,047 $1.33 Million
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $109,528 - $177,179	10,067 Added 8.21%	132,666 $1.58 Million
Q1 2019 May 01, 2019	BUY	$15.51 - $17.61 $4,839 - $5,494	312 Added 0.26%	122,599 $2.16 Million
Q4 2018 Jan 31, 2019	BUY	$14.52 - $19.72 $309,116 - $419,819	21,289 Added 21.08%	122,287 $2.12 Million
Q3 2018 Nov 07, 2018	SELL	$14.85 - $16.35 $47,609 - $52,418	-3,206 Reduced 3.08%	100,998 $1.51 Million
Q2 2018 Aug 06, 2018	BUY	$13.8 - $16.8 $34,776 - $42,336	2,520 Added 2.48%	104,204 $1.66 Million
Q1 2018 May 02, 2018	BUY	$13.8 - $16.2 $43,194 - $50,706	3,130 Added 3.18%	101,684 $1.44 Million
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $182,803 - $213,157	13,491 Added 15.86%	98,554 $1.38 Million
Q3 2017 Nov 06, 2017	BUY	$13.45 - $14.35 $1.14 Million - $1.22 Million	85,063	85,063 $1.22 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account